Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

Background & Aims: Patients with vascular liver diseases (VLD) are at higher risk of both severe courses of COVID-19 disease and thromboembolic events. The impact of SARS-CoV-2 vaccination in patients with VLD has not been described and represents the aim of our study. Methods: International, mu...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Valeria Perez-Campuzano, Pierre-Emmanuel Rautou, Thomas Marjot, Michael Praktiknjo, Edilmar Alvarado-Tapias, Laura Turco, Luis Ibáñez-Samaniego, Carlos González-Alayón, Ángela Puente, Elba Llop, Macarena Simón-Talero, Carmen Álvarez-Navascués, Thomas Reiberger, Xavier Verhelst, Luis Tellez, Johanna Birte Bergmann, Lara Orts, Giuseppe Grassi, Anna Baiges, Payance Audrey, Jonel Trebicka, Candid Villanueva, Maria Cristina Morelli, Sam Murray, Georgina Meacham, Marc Luetgehetmann, Julian Schulze zur Wiesch, Juan-Carlos García-Pagán, Eleanor Barnes, Aurélie Plessier, Virginia Hernández-Gea
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2024-12-01
סדרה:	JHEP Reports
נושאים:	Vascular liver disease COVID-19 vaccine portal thrombosis
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2589555924001952
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!